title: [The present role of prostaglandin analogues in the medical treatment of glaucoma].
abstract: Therapy with prostaglandin analogues (PGA), a novel class of intraocular-lowering medications, represents a safe and very effective pharmacologic method of treating patients with glaucoma and ocular hypertension. The convince dosing regimen, once-daily, higher efficacy and higher systemic safety profile seen with PGA compared with beta-blockers caused that these agents have been approved by regulatory bodies for both the first-line and adjunctive therapy. Short, retrospective analysis of the medical treatment of glaucoma in the Ophthalmology Clinic of Military Health Service Institute in Warsaw, in 2003-2004, was presented.
authors.affiliation: Z Kliniki Okulistyki Wojskowego Instytutu Medycznego w Warszawie.
authors.forename: Joanna
authors.initials: J
authors.lastname: Wierzbowska
authors.forename: Marek
authors.initials: M
authors.lastname: Rekas
authors.forename: Daria
authors.initials: D
authors.lastname: Malawko
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D011453:Prostaglandins / Q000008:administration & dosage*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D011453:Prostaglandins